Dr Hendrik Falk
Oncology
Cancer Therapeutics CRC
Australia
Biography
Dr Hendrik Falk was awarded a B.A. in Business Information Technology and then studied pharmacy at the Martin-Luther Universität Halle/ Germany, receiving the licence to practise in 2000. During his doctoral thesis at the Freie Universität Berlin, Dr Falk examined the involvement of G proteins in cellular signalling. During post-doctoral studies in the Molecular Tumour Genetics group at the Max-Delbrück-Center, Berlin/ Germany, Dr Falk expanded his skills to the high-throughput screening for ligands of G protein coupled receptors. Hendrik brings extensive knowledge in molecular biology as well as biochemical and cellular assays of mammalian cells to the HTCS.
Research Interest
Cell biology
